COMMON STOCK PURCHASE WARRANT To Purchase [ ] Shares of Common Stock of SCOLR PHARMA, INC.SCOLR Pharma, Inc. • April 18th, 2006 • In vitro & in vivo diagnostic substances
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 17, 2006 (the “Initial Exercise Date”) and on or prior to the close of business on April 17, 2011 (the “Termination Date”) but not thereafter, to subscribe for and purchase from SCOLR Pharma, Inc., a Delaware corporation (the “Company”), up to [ ] shares (the “Warrant Shares”) of Common Stock, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $7.50. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. This Warrant is being issued pursuant to that certain Placement Agency Agreement by and among the Company, Taglich Brothers, Inc. and Roth Capital Partners, LLC (the “Placement Agency Agreemen
PLACEMENT AGENCY AGREEMENT April 17, 2006Placement Agency Agreement • April 18th, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances • Washington
SUBSCRIPTION AGREEMENTSubscription Agreement • April 18th, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances • Washington
This subscription agreement (the “Subscription Agreement”) is dated as of April 17, 2006, by and between the investor identified on the signature page hereto (the “Investor”) and SCOLR Pharma, Inc., a Delaware corporation (the “Company”), whereby the parties agree as follows:
